- call +1-201-465-4211
- email sales@mrinsights.biz
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Scope of the Report:
This report focuses on the Leuprolide Acetate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
The worldwide market for Leuprolide Acetate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Intramuscular
Subcutaneous
Market Segment by Applications, can be divided into
Prostate Cancer
Precocious
Uterine Fibroid
Others
There are 15 Chapters to deeply display the global Leuprolide Acetate market.
Chapter 1, to describe Leuprolide Acetate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Leuprolide Acetate, with sales, revenue, and price of Leuprolide Acetate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Leuprolide Acetate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Leuprolide Acetate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Leuprolide Acetate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Leuprolide Acetate Introduction
1.2 Market Analysis by Type
1.2.1 Intramuscular
1.2.2 Subcutaneous
1.3 Market Analysis by Applications
1.3.1 Prostate Cancer
1.3.2 Precocious
1.3.3 Uterine Fibroid
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Tolmar Pharmaceuticals
2.1.1 Business Overview
2.1.2 Leuprolide Acetate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Tolmar Pharmaceuticals Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Varian Pharmed
2.2.1 Business Overview
2.2.2 Leuprolide Acetate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Varian Pharmed Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Avenit
2.3.1 Business Overview
2.3.2 Leuprolide Acetate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Avenit Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda Pharmaceutical
2.4.1 Business Overview
2.4.2 Leuprolide Acetate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Pharmaceutical Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sun Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Leuprolide Acetate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sun Pharmaceutical Industries Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Livzon Pharmaceutical
2.6.1 Business Overview
2.6.2 Leuprolide Acetate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Livzon Pharmaceutical Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Beijing Biote Pharmaceutical
2.7.1 Business Overview
2.7.2 Leuprolide Acetate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Beijing Biote Pharmaceutical Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Soho-YImIng
2.8.1 Business Overview
2.8.2 Leuprolide Acetate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Soho-YImIng Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Leuprolide Acetate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AbbVie Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Leuprolide Acetate Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas Pharma
2.11.1 Business Overview
2.11.2 Leuprolide Acetate Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Astellas Pharma Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Abbott
2.12.1 Business Overview
2.12.2 Leuprolide Acetate Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Abbott Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Leuprolide Acetate Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Merck Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Pfizer
2.14.1 Business Overview
2.14.2 Leuprolide Acetate Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Pfizer Leuprolide Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Leuprolide Acetate Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Leuprolide Acetate Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Leuprolide Acetate Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Leuprolide Acetate Manufacturer Market Share in 2017
3.3.2 Top 6 Leuprolide Acetate Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Leuprolide Acetate Market Analysis by Regions
4.1 Global Leuprolide Acetate Sales, Revenue and Market Share by Regions
4.1.1 Global Leuprolide Acetate Sales and Market Share by Regions (2013-2018)
4.1.2 Global Leuprolide Acetate Revenue and Market Share by Regions (2013-2018)
4.2 North America Leuprolide Acetate Sales and Growth Rate (2013-2018)
4.3 Europe Leuprolide Acetate Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Leuprolide Acetate Sales and Growth Rate (2013-2018)
4.5 South America Leuprolide Acetate Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Leuprolide Acetate Sales and Growth Rate (2013-2018)
5 North America Leuprolide Acetate by Countries
5.1 North America Leuprolide Acetate Sales, Revenue and Market Share by Countries
5.1.1 North America Leuprolide Acetate Sales and Market Share by Countries (2013-2018)
5.1.2 North America Leuprolide Acetate Revenue and Market Share by Countries (2013-2018)
5.2 United States Leuprolide Acetate Sales and Growth Rate (2013-2018)
5.3 Canada Leuprolide Acetate Sales and Growth Rate (2013-2018)
5.4 Mexico Leuprolide Acetate Sales and Growth Rate (2013-2018)
6 Europe Leuprolide Acetate by Countries
6.1 Europe Leuprolide Acetate Sales, Revenue and Market Share by Countries
6.1.1 Europe Leuprolide Acetate Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Leuprolide Acetate Revenue and Market Share by Countries (2013-2018)
6.2 Germany Leuprolide Acetate Sales and Growth Rate (2013-2018)
6.3 UK Leuprolide Acetate Sales and Growth Rate (2013-2018)
6.4 France Leuprolide Acetate Sales and Growth Rate (2013-2018)
6.5 Russia Leuprolide Acetate Sales and Growth Rate (2013-2018)
6.6 Italy Leuprolide Acetate Sales and Growth Rate (2013-2018)
7 Asia-Pacific Leuprolide Acetate by Countries
7.1 Asia-Pacific Leuprolide Acetate Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Leuprolide Acetate Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Leuprolide Acetate Revenue and Market Share by Countries (2013-2018)
7.2 China Leuprolide Acetate Sales and Growth Rate (2013-2018)
7.3 Japan Leuprolide Acetate Sales and Growth Rate (2013-2018)
7.4 Korea Leuprolide Acetate Sales and Growth Rate (2013-2018)
7.5 India Leuprolide Acetate Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Leuprolide Acetate Sales and Growth Rate (2013-2018)
8 South America Leuprolide Acetate by Countries
8.1 South America Leuprolide Acetate Sales, Revenue and Market Share by Countries
8.1.1 South America Leuprolide Acetate Sales and Market Share by Countries (2013-2018)
8.1.2 South America Leuprolide Acetate Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Leuprolide Acetate Sales and Growth Rate (2013-2018)
8.3 Argentina Leuprolide Acetate Sales and Growth Rate (2013-2018)
8.4 Colombia Leuprolide Acetate Sales and Growth Rate (2013-2018)
9 Middle East and Africa Leuprolide Acetate by Countries
9.1 Middle East and Africa Leuprolide Acetate Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Leuprolide Acetate Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Leuprolide Acetate Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Leuprolide Acetate Sales and Growth Rate (2013-2018)
9.3 UAE Leuprolide Acetate Sales and Growth Rate (2013-2018)
9.4 Egypt Leuprolide Acetate Sales and Growth Rate (2013-2018)
9.5 Nigeria Leuprolide Acetate Sales and Growth Rate (2013-2018)
9.6 South Africa Leuprolide Acetate Sales and Growth Rate (2013-2018)
10 Global Leuprolide Acetate Market Segment by Type
10.1 Global Leuprolide Acetate Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Leuprolide Acetate Sales and Market Share by Type (2013-2018)
10.1.2 Global Leuprolide Acetate Revenue and Market Share by Type (2013-2018)
10.2 Intramuscular Sales Growth and Price
10.2.1 Global Intramuscular Sales Growth (2013-2018)
10.2.2 Global Intramuscular Price (2013-2018)
10.3 Subcutaneous Sales Growth and Price
10.3.1 Global Subcutaneous Sales Growth (2013-2018)
10.3.2 Global Subcutaneous Price (2013-2018)
11 Global Leuprolide Acetate Market Segment by Application
11.1 Global Leuprolide Acetate Sales Market Share by Application (2013-2018)
11.2 Prostate Cancer Sales Growth (2013-2018)
11.3 Precocious Sales Growth (2013-2018)
11.4 Uterine Fibroid Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Leuprolide Acetate Market Forecast (2018-2023)
12.1 Global Leuprolide Acetate Sales, Revenue and Growth Rate (2018-2023)
12.2 Leuprolide Acetate Market Forecast by Regions (2018-2023)
12.2.1 North America Leuprolide Acetate Market Forecast (2018-2023)
12.2.2 Europe Leuprolide Acetate Market Forecast (2018-2023)
12.2.3 Asia-Pacific Leuprolide Acetate Market Forecast (2018-2023)
12.2.4 South America Leuprolide Acetate Market Forecast (2018-2023)
12.2.5 Middle East and Africa Leuprolide Acetate Market Forecast (2018-2023)
12.3 Leuprolide Acetate Market Forecast by Type (2018-2023)
12.3.1 Global Leuprolide Acetate Sales Forecast by Type (2018-2023)
12.3.2 Global Leuprolide Acetate Market Share Forecast by Type (2018-2023)
12.4 Leuprolide Acetate Market Forecast by Application (2018-2023)
12.4.1 Global Leuprolide Acetate Sales Forecast by Application (2018-2023)
12.4.2 Global Leuprolide Acetate Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Leuprolide Acetate Picture
Table Product Specifications of Leuprolide Acetate
Figure Global Sales Market Share of Leuprolide Acetate by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
